| 000 | 01654 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250513201225.0 | ||
| 264 | 0 | _c20000201 | |
| 008 | 200002s 0 0 eng d | ||
| 022 | _a1460-2725 | ||
| 024 | 7 |
_a10.1093/qjmed/92.7.387 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWierzbicki, A S | |
| 245 | 0 | 0 |
_aAtorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias. _h[electronic resource] |
| 260 |
_bQJM : monthly journal of the Association of Physicians _cJul 1999 |
||
| 300 |
_a387-94 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnticholesteremic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aAtorvastatin |
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 |
_aCholesterol, HDL _xblood |
| 650 | 0 | 4 |
_aCholesterol, LDL _xblood |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aFibrinogen _xanalysis |
| 650 | 0 | 4 |
_aHeptanoic Acids _xadministration & dosage |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipidemia, Familial Combined _xblood |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 |
_aPyrroles _xadministration & dosage |
| 650 | 0 | 4 |
_aRhabdomyolysis _xchemically induced |
| 650 | 0 | 4 |
_aSimvastatin _xtherapeutic use |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 700 | 1 | _aLumb, P J | |
| 700 | 1 | _aSemra, Y | |
| 700 | 1 | _aChik, G | |
| 700 | 1 | _aChrist, E R | |
| 700 | 1 | _aCrook, M A | |
| 773 | 0 |
_tQJM : monthly journal of the Association of Physicians _gvol. 92 _gno. 7 _gp. 387-94 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/qjmed/92.7.387 _zAvailable from publisher's website |
| 999 |
_c10583350 _d10583350 |
||